Additionally, we discuss the therapeutic potential of GDF-15 inhibitors, either as monotherapy or in combination with other treatments, with a particular focus on head and neck cancers (HNC) as an example of malignancies with a high risk of malnutrition and cachexia due to both disease burden and treatment-related factors. This evidence concerns the gene GDF15 and malnutrition.